RecruitingNCT07312526
Shanghai Clinical Cohort - Esophageal Cancer
Shanghai Clinical Cohort - Esophageal Cancer Cohort
Sponsor
Shanghai Chest Hospital
Enrollment
2,116 participants
Start Date
Jul 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
A prospective cohort of patients who received esophagectomy for esophageal cancer in participating centers.
Eligibility
Plain Language Summary
Simplified for easier understanding
This study builds a clinical database of patients who have undergone oesophagectomy (surgery to remove the oesophagus/food pipe) for oesophageal cancer in Shanghai hospitals. It collects data on surgical outcomes and long-term results to improve understanding and treatment of this cancer.
**You may be eligible if...**
- You had surgery (oesophagectomy) to treat oesophageal cancer at one of the participating centres
**You may NOT be eligible if...**
- You did not have oesophagectomy
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREesophagectomy
esophagectomy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07312526
Related Trials
The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy
NCT071871541 location
Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy
NCT073099916 locations
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
NCT075785711 location
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
NCT0669584528 locations
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
NCT0558100441 locations